Skip to main content
Fig. 1 | Gut Pathogens

Fig. 1

From: A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn’s disease associated with Mycobacterium avium subspecies paratuberculosis

Fig. 1

Effect of the proprietary RHB-104 capsule formulation and RHB-104 analog on culture growth of MAP MS 137, M. smegmatis, L. monocytogenes and S. aureus. * MIC level in μg/mL. ** The proprietary RHB-104 capsule formulation dissolved in one compatible solvent. *** RHB-104 analog (a mixture of individually dissolved 63.3 % Clarithromycin (CLA), 6.7 % Clofazimine (CLO) and 30 % Rifabutin (RIF), equal to  %composition in the proprietary RHB-104 capsule formulation)

Back to article page

Gut Pathogens

ISSN: 1757-4749